Brand-name drug makers are focused on profits Final Edition

Brand-name drug makers would have us believe that reforming drug patent laws to stop them from adding patent after patent onto the same drug to block competition is a threat to the next cure or blockbuster treatment. Brand-name drug companies should spend their money finding new medicines instead of...

Full description

Saved in:
Bibliographic Details
Published inThe Ottawa citizen (1986)
Main Author Wagg, Larry
Format Newspaper Article
LanguageEnglish
Published Ottawa, Ont Postmedia Network Inc 26.02.2003
Online AccessGet full text

Cover

More Information
Summary:Brand-name drug makers would have us believe that reforming drug patent laws to stop them from adding patent after patent onto the same drug to block competition is a threat to the next cure or blockbuster treatment. Brand-name drug companies should spend their money finding new medicines instead of putting multiple patents on the same drug and blowing millions of dollars on TV ads and inducements to doctors.
ISSN:0839-3222